Vilobelimab?s effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT - Milan 2023

Hot topics in intensive care medicine

Chair(s): Ana Cysneiros, Lieuwe D.J. Bos

Session type: Oral presentation

Vilobelimab?s effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT

Endry Lim

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - CLUSTERING ARDS PATIENTS THROUGH THE FIRST DAYS OF ICU ADMISSION.

Adrian Ceccato

Replay

Poster

Abstract

Slides

Late Breaking Abstract - Transcriptome profiling of persistent ICU-acquired weakness in a cohort of ARDS survivors

Israel David Duarte Herrera

Replay

Poster

Abstract

Slides

The association between respiratory effort parameters during the first 48 hours with clinical outcomes in mechanically ventilated patients: A prospective observational study.

Phruet Soipetkasem

Replay

Poster

Abstract

Slides

Differences in nosocomial infections in patients on VV-ECMO for COVID-19 and Influenza

Clemens Wiest

Replay

Abstract

Slides

Vilobelimabs effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT

Endry Lim

Replay

Poster

Abstract

Slides

Dead-space ventilation indices and mortality in acute respiratory distress syndrome: a systematic review and meta-analysis.

Dilip Jayasimhan

Replay

Poster

Abstract

Slides

long-term outcomes in critical covid-19 survivors: a 2-year longitudinal cohort

Jessica Gonzalez Gutierrez

Replay

Poster

Abstract

Slides

Lung microbiota compositions differ between influenza, COVID-19 and bacteria-related acute respiratory distress syndrome

Renaud Prevel

Replay

Poster

Abstract

Slides

Tranexamic acid to treat hemoptysis in real life (ATHENE study)

Marie Gaffier

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}